News for Healthier Living
GLP-1 Shows Promise for Patients with Advanced Fatty Liver Disease
GLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large global trial study.
July 16, 2026
July 25 2026July 24 2026July 23 2026July 22 2026July 21 2026July 20 2026July 17 2026July 16 2026July 15 2026July 14 2026July 13 2026July 12 2026
|
|
|
|
|